These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 14054727

  • 21. THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW.
    COLE JO, KATZ MM.
    JAMA; 1964 Mar 07; 187():758-61. PubMed ID: 14094299
    [No Abstract] [Full Text] [Related]

  • 22. [Hallucinogens logally classified as narcotics].
    Med Monatsschr; 1967 May 07; 21(5):214-5. PubMed ID: 5633461
    [No Abstract] [Full Text] [Related]

  • 23. [Hallucinogenic substances].
    Ginestet D.
    Maroc Med; 1967 Jun 07; 47(503):429-33. PubMed ID: 5619732
    [No Abstract] [Full Text] [Related]

  • 24. Deceptions in the illicit drug market.
    Cheek FE, Newell S, Joffe M.
    Science; 1970 Feb 27; 167(3922):1276. PubMed ID: 5460848
    [No Abstract] [Full Text] [Related]

  • 25. [THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].
    FERNANDEZ-CERDENO A, LEUNER H.
    Z Psychosom Med; 1965 Feb 27; 11():45-54. PubMed ID: 14301325
    [No Abstract] [Full Text] [Related]

  • 26. [COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
    KANDIC B, DORDEVIC D.
    Vojnosanit Pregl; 1963 May 27; 20():275-9. PubMed ID: 14067329
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [PRACTICAL EXPERIENCES WITH HALLUCINOGENS IN PSYCHOTHERAPY].
    HAUSNER M, DOLEZAL V.
    Cesk Psychiatr; 1963 Oct 27; 59():328-35. PubMed ID: 14111793
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Investigations of behavior and experimental psychoses].
    Leuner H.
    Bibl Psychiatr; 1971 Oct 27; 147():164-76. PubMed ID: 5554608
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hallucinogenic drugs.
    Anesth Analg; 1968 Oct 27; 47(1):72-6. PubMed ID: 4866081
    [No Abstract] [Full Text] [Related]

  • 34. [LSD and related hallucinogens. History--effect--use and dangers].
    Hole G.
    Munch Med Wochenschr; 1967 Jun 30; 109(26):1389-97. PubMed ID: 4874820
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM, Appel JB.
    J Pharmacol Exp Ther; 1988 Sep 30; 246(3):866-70. PubMed ID: 2901488
    [Abstract] [Full Text] [Related]

  • 38. The psychology of hallucinogenic drug discontinuers.
    Salzman C, Lieff J, Kochansky GE, Shader RI.
    Am J Psychiatry; 1972 Dec 30; 129(6):755-61. PubMed ID: 4404760
    [No Abstract] [Full Text] [Related]

  • 39. THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS.
    Alnaes R.
    Acta Psychiatr Scand; 1964 Dec 30; 39(S180):397-409. PubMed ID: 14345225
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.